concept

LEVODOPA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LEVODOPA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

135Connections

0Hypotheses

0Analyses

33Outgoing

20Incoming

No summary available yet. View on Wiki →

💡 Concept Info

Name	LEVODOPA
Key Genes/Proteins	COMT, PARKIN, STING, GBA, DRD2, TH
Related Diseases	PARKINSON'S DISEASE, PARKINSON, ATAXIA, DOPAMINE

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    LEVODOPA["LEVODOPA"]
    LEVODOPA -->|"treats"| Parkinson_s_Disease["Parkinson's Disease"]
    LEVODOPA -->|"causes"| Adverse_Drug_Reactions["Adverse Drug Reactions"]
    LEVODOPA -->|"treats"| Parkinson_s_disease["Parkinson's disease"]
    LEVODOPA -->|"converts_to"| dopamine["dopamine"]
    LEVODOPA -->|"causes"| dyskinesias["dyskinesias"]
    LEVODOPA -->|"activates"| NEURON["NEURON"]
    DOPAMINERGIC_NEURONS["DOPAMINERGIC NEURONS"] -->|"activates"| LEVODOPA
    CORTEX["CORTEX"] -->|"regulates"| LEVODOPA
    FRONTOTEMPORAL_DEMENTIA["FRONTOTEMPORAL DEMENTIA"] -->|"causes"| LEVODOPA
    ALS["ALS"] -->|"causes"| LEVODOPA

Outgoing (114)

Target	Relation	Type	Str
PARKINSON'S DISEASE	treats	disease	0.80
PARKINSON'S DISEASE	activates	disease	0.70
COMT	activates	gene	0.70
NEURON	promotes	cell_type	0.65
NEURONS	promotes	cell_type	0.65
PARKIN	treats	gene	0.65
PARKINSON	treats	disease	0.65
STING	targets	gene	0.65
GBA	exacerbates	gene	0.65
PARKINSON'S DISEASE	inhibits	disease	0.65
NEURON	activates	cell_type	0.50
NEURON	therapeutic_target	cell_type	0.50
NEURON	produces	cell_type	0.50
COMT	associated_with	gene	0.50
DDC	associated_with	gene	0.50
TAU	associated_with	protein	0.50
NEURONS	associated_with	cell_type	0.45
DOPAMINE	associated_with	phenotype	0.45
NEURON	associated_with	cell_type	0.45
ALS	associated_with	disease	0.45
AMPK	associated_with	gene	0.45
BDNF	associated_with	gene	0.45
NRF2	associated_with	gene	0.45
AKT	associated_with	gene	0.45
PARKIN	associated_with	gene	0.45
PINK1	associated_with	gene	0.45
GBA	associated_with	gene	0.45
SUBSTANTIA NIGRA	activates	brain_region	0.35
PARKINSON'S DISEASE	therapeutic_target	disease	0.35
PARKINSON'S DISEASE	protects_against	disease	0.35
VEGF	inhibits	gene	0.35
PARKINSON'S DISEASE	causes	disease	0.35
MOTOR NEURONS	causes	cell_type	0.35

Incoming (21)

Source	Relation	Type	Str
DRD2	associated_with	gene	0.65
ATAXIA	mediates	disease	0.65
DOPAMINE	activates	phenotype	0.65
TH	activates	gene	0.65
TH	treats	gene	0.65
PARKINSON'S DISEASE	associated_with	disease	0.50
PARKINSON	associated_with	disease	0.50
SEROTONIN	associated_with	phenotype	0.50
NEURODEGENERATION	associated_with	phenotype	0.50
DOPAMINE	associated_with	phenotype	0.45
ALS	associated_with	disease	0.45
CARBIDOPA	associated_with	drug	0.45
SPINOCEREBELLAR ATAXIA	associated_with	disease	0.45
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	disease	0.45
UBIQUITIN	associated_with	protein	0.45
SEMAGLUTIDE	associated_with	drug	0.45
DOPAMINERGIC NEURONS	activates	cell_type	0.35
CORTEX	regulates	brain_region	0.35
FRONTOTEMPORAL DEMENTIA	causes	disease	0.35
ALS	causes	disease	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

LEVODOPA

Understanding Entity Pages

Wiki Pages (21)

ai-enhanced-levodopa-challenge-test-nct06949865

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Parkinson's Disease

CBS/PSP Supplements Guide

Atypical Parkinsonism

Device Therapies Comparison for CBS/PSP

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Corticobasal Degeneration (CBD)

Therapeutics

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

Frontotemporal Dementia (FTD) Mechanistic Pathway

CBS/PSP Treatment Rankings

GRIA3 Gene